NF kappa B is a critical
transcription factor involved in modulating cellular responses to environmental
injuries.
Tyrosine 42 phosphorylation of
I kappa B alpha has been shown to mediate
NF kappa B activation following
hypoxia/reoxygenation (H/R) or
pervanadate treatment. This pathway differs from the canonical proinflammatory pathways, which mediate
NF kappa B activation through
serine phosphorylation of
I kappa B alpha by the IKK complex. In the present study, we investigated the involvement of c-Src in the redox activation of NFkappaB following H/R or
pervanadate treatment. Our results demonstrate that
pervanadate or H/R treatment leads to
tyrosine phosphorylation of
I kappa B alpha and
NF kappa B transcriptional activation independent of the IKK pathway. In contrast, inhibition of c-Src by pp2 treatment or in c-Src (-/-) knockout cell lines, demonstrated a significant reduction in
I kappa B alpha
tyrosine phosphorylation and
NF kappa B activation following
pervanadate or H/R treatment. Overexpression of
glutathione peroxidase-1 or
catalase, but not
Mn-SOD or Cu,Zn-SOD, significantly reduced both
NF kappa B activation and
tyrosine phosphorylation of
I kappa B alpha. In vitro
kinase assays further demonstrated that immunoprecipitated c-Src has the capacity to directly phosphorylate GST-
I kappa B alpha and that this
I kappa B alpha
kinase activity is significantly reduced by Gpx-1 overexpression. These results suggest that c-Src-dependent
tyrosine phosphorylation of
I kappa B alpha and subsequent activation of
NF kappa B is controlled by intracellular H(2)O(2) and defines an important redox-regulated pathway for
NF kappa B activation following H/R injury that is independent of the IKK complex.